Search results
Massachusetts Financial Services Co. MA Boosts Holdings in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 16 hours agoMassachusetts Financial Services Co. MA raised its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 8.6% in the fourth quarter, according to the company in its most ...
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
Motley Fool via Yahoo Finance· 5 days agoAdditionally, Catalyst's expansion into the Duchenne...valuation of Catalyst, trading at under 3...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoThe biotech soared 190% in two trading sessions after announcing a $1.2 billion vaccine-licensing deal with French pharmaceutical giant Sanofi. The...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell? | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX -4.30%) took a turn in the investor spotlight in early May, when the vaccine...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 4 days agoTogether with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 4 days agoNovavax entered the coronavirus vaccine market late, missing out on the biggest revenue opportunity. This disappointed investors, and the stock plummeted...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 5 days agoThe New York-based pharmaceutical giant will pay plaintiffs between $200 million and $250 million to...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 6 days agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
Earnings call: DarioHealth projects growth and profitability by 2025 By Investing.com
Investing.com· 5 days agoIn a recent earnings call, DarioHealth Corp (NASDAQ:DRIO) CEO Erez Raphael outlined the company's...
